摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl (2R)-2-acetamido-3-(4-hydroxyphenyl)propanoate | 65160-71-6

中文名称
——
中文别名
——
英文名称
methyl (2R)-2-acetamido-3-(4-hydroxyphenyl)propanoate
英文别名
——
methyl (2R)-2-acetamido-3-(4-hydroxyphenyl)propanoate化学式
CAS
65160-71-6
化学式
C12H15NO4
mdl
——
分子量
237.255
InChiKey
KRMVXLWZDYZILN-LLVKDONJSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    132-133 °C
  • 沸点:
    457.0±35.0 °C(Predicted)
  • 密度:
    1?+-.0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.3
  • 重原子数:
    17
  • 可旋转键数:
    5
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    75.6
  • 氢给体数:
    2
  • 氢受体数:
    4

SDS

SDS:645b40249f01058c1dc0aba2a9c67538
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    methyl (2R)-2-acetamido-3-(4-hydroxyphenyl)propanoate盐酸 作用下, 以 甲醇 为溶剂, 反应 18.0h, 生成 (R)-2-Acetylamino-3-{4-[3-((R)-amino-methoxycarbonyl-methyl)-phenoxy]-phenyl}-propionic acid methyl ester
    参考文献:
    名称:
    Studies on the synthesis of aryl ethers using arene-manganese chemistry
    摘要:
    Selective arylation of polyfunctional phenols, using chlorobenzene- and p-chlorotoluene-manganese tricarbonyl cations, is described. The intermediate arene-manganese complexes are found to undergo stereo- and regioselective reactions with Schollkopf's chiral glycine enolate equivalent to give dienyl-Mn(CO)3 complexes. Treatment of these complexes with N-bromosuccinimide at room temperature, followed by hydrolysis of the dihydropyrazine, gives diaryl ethers in which one of the aromatic rings is an arylglycine methyl ester.
    DOI:
    10.1021/jo00025a026
  • 作为产物:
    描述:
    D-酪氨酸甲酯 以68%的产率得到methyl (2R)-2-acetamido-3-(4-hydroxyphenyl)propanoate
    参考文献:
    名称:
    Studies on the synthesis of aryl ethers using arene-manganese chemistry
    摘要:
    Selective arylation of polyfunctional phenols, using chlorobenzene- and p-chlorotoluene-manganese tricarbonyl cations, is described. The intermediate arene-manganese complexes are found to undergo stereo- and regioselective reactions with Schollkopf's chiral glycine enolate equivalent to give dienyl-Mn(CO)3 complexes. Treatment of these complexes with N-bromosuccinimide at room temperature, followed by hydrolysis of the dihydropyrazine, gives diaryl ethers in which one of the aromatic rings is an arylglycine methyl ester.
    DOI:
    10.1021/jo00025a026
点击查看最新优质反应信息

文献信息

  • New cyclic peptides via ring-closing metathesis reactions and their anti-bacterial activities
    作者:Timothy P. Boyle、John B. Bremner、Jonathan Coates、John Deadman、Paul A. Keller、Stephen G. Pyne、David I. Rhodes
    DOI:10.1016/j.tet.2008.09.031
    日期:2008.12
    As part of a program investigating cyclic peptides with an internal aromatic hydrophobic scaffold as potential novel anti-bacterial agents, we explored the synthesis of simple tyrosine-based systems. These were prepared via key intermediates containing internal allylglycine and allyltyrosine residues for subsequent ring-closing metathesis reactions. Although the resulting anti-bacterial activity against
    作为研究带有内部芳香族疏水支架作为潜在新型抗菌剂的环肽的计划的一部分,我们探索了基于酪氨酸的简单系统的合成。这些是通过含有内部烯丙基甘氨酸和烯丙基酪氨酸残基的关键中间体制备的,用于随后的闭环易位反应。尽管所产生的针对金黄色葡萄球菌的抗菌活性适中,但这代表了这类化合物的新颖而简单的途径。一种中间体无环二肽前体显示出对金黄色葡萄球菌的良好活性,MIC为7.8μg/ mL。
  • A highly effective phosphinite ligand derived from D-mannitol for Rh-catalyzed asymmetric hydrogenation
    作者:Yixin Chen、Xingshu Li、Siu-kuen Tong、Michael C.K. Choi、Albert S.C. Chan
    DOI:10.1016/s0040-4039(98)02457-5
    日期:1999.1
    chiral phosphinite 1,2,5,6-di-isopropylidene-3,4-bis(diphenylphosphino)-D-mannitol was prepared and its rhodium complex was found to be an effective catalyst for the asymmetric hydrogenation of amidoacrylic acid and its derivatives with product ee's ranging from 90% to 97%.
    制备了一种新型的手性次膦酸酯1,2,5,6-二异亚丙基-3,4-双(二苯基膦基)-D-甘露醇,发现其铑配合物是酰胺基丙烯酸及其不对称加氢的有效催化剂。产品ee介于90%至97%之间的衍生产品。
  • Novel Lysophosphatidic Acid Receptor Selective Antagonists
    申请人:Lynch Kevin R.
    公开号:US20080318901A1
    公开(公告)日:2008-12-25
    The present invention is directed to compositions comprising lysophosphatidic acid analogs and methods of using such analogs as agonist or antagonists of LPA receptor activity. In addition the invention is directed to LPA receptor agonists that vary in the degree of selectivity at individual LPA receptors (i.e. LPA1, LPA2 and LPA3). More particularly the present invention is directed to LPA analogs wherein the glycerol is replaced with ethanolamine and a variety of substitutions have been linked at the second carbon atom.
    本发明涉及包含溶血磷脂酸类似物的组合物以及使用这些类似物作为LPA受体活性的激动剂或拮抗剂的方法。此外,本发明涉及在单个LPA受体(即LPA1,LPA2和LPA3)的选择度方面有所不同的LPA受体激动剂。更具体地,本发明涉及LPA类似物,其中甘油被乙醇胺取代,并且在第二个碳原子上连接了各种替代基。
  • Peptidic Compounds
    申请人:Boyle Timothy Patrick
    公开号:US20080300287A1
    公开(公告)日:2008-12-04
    The present invention provides a compound of formula (I), (II), (III) and (IV) as defined herein and pharmaceutically acceptable derivatives thereof. The present invention further provides use of the compounds of the present invention in the treatment of bacterial infection and in the treatment of HIV infection. Also provided are pharmaceutical compositions comprising the compounds of the present invention.
    本发明提供了公式(I)、(II)、(III)和(IV)的化合物及其药学上可接受的衍生物。本发明进一步提供了本发明化合物在治疗细菌感染和治疗HIV感染中的用途。还提供了包含本发明化合物的制药组合物。
  • PEPTIDIC COMPOUNDS
    申请人:Boyle Timothy Patrick
    公开号:US20110312875A1
    公开(公告)日:2011-12-22
    The present invention provides a compound of formula I, II, III and IV as defined herein and pharmaceutically acceptable derivatives thereof. The present invention further provides use of the compounds of the present invention in the treatment of bacterial infection and in the treatment of HIV infection. Also provided are pharmaceutical compositions comprising the compounds of the present invention.
    本发明提供了公式I、II、III和IV的化合物及其药学上可接受的衍生物。本发明还提供了利用本发明化合物治疗细菌感染和治疗HIV感染的用途。此外,还提供了包含本发明化合物的制药组合物。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物